Octave Bioscience - About the company
Octave Bioscience is a series C company based in Menlo Park (United States), founded in 2014 by William Hagstrom and Melinda Thomas. It operates as a Provider of AI-based molecular diagnostic tools for neurodegenrative diseases. Octave Bioscience has raised $124M in funding from investors like Novartis, Merck Global Health Innovation Fund and Intermountain Ventures. The company has 44 active competitors, including 14 funded and 5 that have exited. Its top competitors include companies like Amprion, PeopleBio R&D and Cytox.
Company Details
Provider of AI-based molecular diagnostic tools for neurodegenerative diseases. The company has developed the first blood test to measure disease activity at the biology level. The platform will captures data using sensors, wearables & mobile tools to identify changes in disease status and optimize images adding quantitation, serial trends.
- Website
- octavebio.com
- Social
- Email ID
- *****@octavebio.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2014
Location
Menlo Park, United States
Stage
Series C
Total Funding
$124M in 9 rounds
Latest Funding Round
Ranked
1st among 44 active competitors
Employee Count
83 as on Mar 31, 2026
Sign up to download Octave Bioscience's company profile
Octave Bioscience's funding and investors
Octave Bioscience has raised a total funding of $124M over 9 rounds. Its first funding round was on Sep 13, 2017. Its latest funding round was a Conventional Debt round on Sep 04, 2025 for $*****. 1 investor participated in its latest round. Octave Bioscience has 16 institutional investors.
Here is the list of recent funding rounds of Octave Bioscience:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Sep 04, 2025 | 5537684 | Conventional Debt | 1462164 | 5396096 | 7505148 | 6910184 |
Mar 07, 2025 | 1215272 | Series C | 2892936 | 7919683 | 8920356 | |
Nov 16, 2023 | 8450582 | Grant (prize money) | 6224384 | 5353552 | 8510988 |
Access funding benchmarks and valuations. Sign up today!View details of Octave Bioscience's funding rounds and investors
Octave Bioscience's founders and board of directors
Founder? Claim ProfileThe founders of Octave Bioscience are William Hagstrom and Melinda Thomas. William Hagstrom and Doug Biehn are the CEOs of Octave Bioscience.
Here are the details of Octave Bioscience's key team members:
- William Hagstrom: Co-Founder & CEO of Octave Bioscience and founder of 2 other companies, Quadrotian and Biolytx. They serve on the board of 1 company.
- Melinda Thomas: Former Co-Founder & COO of Octave Bioscience. Contact Info: 1 email address
- Doug Biehn: CEO of Octave Bioscience.
View details of Octave Bioscience's Founder profiles and Board Members
Octave Bioscience's employee count trend
Octave Bioscience has 83 employees as of Mar 26. Here is Octave Bioscience's employee count trend over the years:
Uncover Octave Bioscience's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Octave Bioscience's Competitors and alternates
Top competitors of Octave Bioscience include Amprion, PeopleBio R&D and Cytox. Here is the list of Top 10 competitors of Octave Bioscience, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Octave Bioscience 2014, Menlo Park (United States), Series C | Provider of AI-based molecular diagnostic tools for neurodegenrative diseases | $124M | 65/100 | |
2nd | Amprion 2006, Houston (United States), Series B | Revolutionizing neurodegenerative disease diagnosis with advanced α-synuclein detection technology | $11.8M | 56/100 | |
3rd | PeopleBio R&D 2002, Seongnam-si (South Korea), Public | Immunoassays for early detection of neuro-degenerative diseases | - | 46/100 | |
4th | Cytox 2007, Oxford (United Kingdom), Series B | Developer for prognostic tests for assessing the risk of dementia | $12.1M | 43/100 | |
5th | Developer of diagnostic tests to detect cancers, cardiovascular and neurodegenerative diseases | - | 40/100 | ||
6th | ADx NeuroSciences 2011, Ghent (Belgium), Acquired | Biomarker assays for neurodegenerative diseases | $3.17M | 36/100 | |
7th | Gene Solutions 2006, Charlottesville (United States), Series A | Pioneering mitochondrial medicine, developing therapeutics for neurodegenerative and muscular diseases | $6.33M | - | 34/100 |
8th |  LikeMinds 2008, Boston (United States), Series A | Provider of dopamine transporter imaging agent for diagnosis of neurodegenerative diseases | $6.37M | - | 33/100 |
9th | Abiant 2006, Grayslake (United States), Deadpooled | Imaging tools for diagnosis of neurodegenerative diseases | $600K | 32/100 | |
10th |  Durin Technologies 2010, Camden (United States), Series B | Developer of the diagnostic test for neurodegenerative diseases | $8.05M | 32/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Octave Bioscience's competitors? Click here to see the top ones
Octave Bioscience's Investments and acquisitions
Octave Bioscience has made no investments or acquisitions yet.
News related to Octave Bioscience
Filter this listMedia has covered Octave Bioscience for a total of 6 events in the last 1 year, 1 of them has been about company updates and 1 about partnerships.
•
•
•
Octave Bioscience Secures $35M Series C to Boost Commercial GrowthBusiness Wire•Sep 05, 2025•Octave Bioscience, Valhalla, Northpond Ventures, S32 and 8 others
•
Rapafusyn Pharmaceuticals Closes $44 Million Series A Financing for Molecular Glue Drug Discovery PlatformAgencia EFE•Sep 04, 2025•Rapafusyn, Yonjin Capital, BioTrack Capital, 3E Bioventures Capital and 5 others
•
•
•
Octave® Bioscience, Inc. Announces Publication in Nature CommunicationsBusiness Wire•May 29, 2024•Octave Bioscience
•
•
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Octave Bioscience
Explore our recently published companies
- AKY DEVA - Gurugram based, 2023 founded, Unfunded company
- Elivaux - Chandigarh based, 2022 founded, Unfunded company
- Agrigator - Unfunded company
- Koushik Software Solutions - Visakhapatnam based, 2024 founded, Unfunded company
- AutoCarWash India - Hyderabad based, 2025 founded, Unfunded company
- Ditchwitch - Unfunded company
